Leticia Martínez González

Área Transversal

Orcid ID:
Scopus Author:
Categoría docente:
Nivel de Titulación:

Unidades de Investigación:




Currículum vitae

I am Nurse in the urology department of the Marqués de Valdecilla University Hospital, with 9 years of experience in clinical practice in different areas of nursing and in different Spanish hospitals. I have completed a Master in innovation and health sciences and I have a PhD in biomedicine and health sciences from the University of León, León (España). I have been an honorary collaborator of the Nursing Department of the University of Cantabria in the academic year 2014-2015. I am Investigator in the gene-environment-health interactions in the University of León. I am also part of the nursing research team at Idival since June 2022. I am current research is focused on understnding the interaction between eating disorders and drugs and how it applies to stress and psychiatric- related disorders at key time-windows across the lifespan. I have made numerous scientific publications in high impact JCR journals such as the "International Journal of Environmental Research and Public Health" or " Hospital Nutrition" among others, book publications and I have presented around 100 scientific communications in national and international congresses. I had published over 20 peer-reviewed articles and book chapters and have a H-index of 7 (Google Scholar). I have a Senior Review of Preventive Medicine and Spanish Journal of Human Nutrition and Dietetics. I received the award for the best oral communication "risk of eating disorders in university students: UNIHCOS PROJECT" in the VII Regional Congress of Nursing of Castilla y León. I am part of the scientific committee of the national and international nursing congress organized by the Spanish Association of Nursing and Health since 2020. I have participated as a Collaborator in two research projects since 2018: - Phase II, multicenter, international, double-blind, two-group, randomized, placebo-controlled, multicenter trial of pirfenidone in patients with progressive unclassifiable epifibrosing (MA39189) (ROCHE PRODUCTS LIMITED)-. - Double-masked, multicenter, placebo-controlled, double-blinded clinical trial to investigate the efficacy and safety of 12 months of inhaled Promixin® (sodium colistimethate) therapy for the treatment of patients with non-cystic fibrosis bronchiectasis with chronic Pseudomonas aeruginosa (P. aeruginosa) infection (Z7224L01) (ZAMBON SPA).


Producción Científica

Se muestra en este gráfico el desglose por producto de la producción científica del investigador.

Evolución de publicaciones por Cuartiles

Se muestra en este gráfico la evolución de las publicaciones del investigador en los últimos cinco años, donde se indica el porcentaje de estas publicaciones en cada uno de los cuartiles por anualidad.

Factor de Impacto y Citas Totales

Se muestra en este gráfico la evolución del factor de impacto acumulado y las citas totales recibidas por las publicaciones del investigador en los últimos cinco años, con el desglose por anualidad.

Colaboraciones internacionales

Se muestra en este mapa el detalle de todas las instituciones con las que se ha colaborado el investigador en el ámbito de los productos de investigación. Se informa de la relación de instituciones por cada país.